207 related articles for article (PubMed ID: 36700398)
1. Duality of Nrf2 in iron-overload cardiomyopathy.
Federti E; Vinchi F; Iatcenko I; Ghigo A; Matte A; Toya SCM; Siciliano A; Chiabrando D; Tolosano E; Vance SZ; Riccardi V; Andolfo I; Iezzi M; Lamolinara A; Iolascon A; De Franceschi L
Haematologica; 2023 May; 108(5):1335-1348. PubMed ID: 36700398
[TBL] [Abstract][Full Text] [Related]
2. Advanced iron-overload cardiomyopathy in a genetic murine model is rescued by resveratrol therapy.
Das SK; Zhabyeyev P; Basu R; Patel VB; Dyck JRB; Kassiri Z; Oudit GY
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29208771
[TBL] [Abstract][Full Text] [Related]
3. Females Are Protected From Iron-Overload Cardiomyopathy Independent of Iron Metabolism: Key Role of Oxidative Stress.
Das SK; Patel VB; Basu R; Wang W; DesAulniers J; Kassiri Z; Oudit GY
J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28115312
[TBL] [Abstract][Full Text] [Related]
4. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment of cardiac iron overload in transfusion-dependent thalassemia patients.
Siri-Angkul N; Chattipakorn SC; Chattipakorn N
Expert Rev Hematol; 2018 Jun; 11(6):471-479. PubMed ID: 29754517
[TBL] [Abstract][Full Text] [Related]
6. Astragalus polysaccharide upregulates hepcidin and reduces iron overload in mice via activation of p38 mitogen-activated protein kinase.
Ren F; Qian XH; Qian XL
Biochem Biophys Res Commun; 2016 Mar; 472(1):163-8. PubMed ID: 26915800
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor NRF2 protects mice against dietary iron-induced liver injury by preventing hepatocytic cell death.
Silva-Gomes S; Santos AG; Caldas C; Silva CM; Neves JV; Lopes J; Carneiro F; Rodrigues PN; Duarte TL
J Hepatol; 2014 Feb; 60(2):354-61. PubMed ID: 24021424
[TBL] [Abstract][Full Text] [Related]
8. Liver expression of hepcidin and other iron genes in two mouse models of beta-thalassemia.
De Franceschi L; Daraio F; Filippini A; Carturan S; Muchitsch EM; Roetto A; Camaschella C
Haematologica; 2006 Oct; 91(10):1336-42. PubMed ID: 17018382
[TBL] [Abstract][Full Text] [Related]
9. Cardiomyopathy associated with iron overload: how does iron enter myocytes and what are the implications for pharmacological therapy?
Wijarnpreecha K; Kumfu S; Chattipakorn SC; Chattipakorn N
Hemoglobin; 2015; 39(1):9-17. PubMed ID: 25572185
[TBL] [Abstract][Full Text] [Related]
10. mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models.
Weizer-Stern O; Adamsky K; Amariglio N; Rachmilewitz E; Breda L; Rivella S; Rechavi G
Am J Hematol; 2006 Jul; 81(7):479-83. PubMed ID: 16755567
[TBL] [Abstract][Full Text] [Related]
11. Relation of hepcidin gene expression in blood mononuclear cells with iron overload severity among β-thalassemia major patients.
Ayatollahi H; Mousavi Nezhad SF; Talebpour A; Badiei Z; Nezami H
Mol Biol Rep; 2020 Dec; 47(12):9353-9359. PubMed ID: 33231816
[TBL] [Abstract][Full Text] [Related]
12. Iron and oxidative stress in cardiomyopathy in thalassemia.
Berdoukas V; Coates TD; Cabantchik ZI
Free Radic Biol Med; 2015 Nov; 88(Pt A):3-9. PubMed ID: 26216855
[TBL] [Abstract][Full Text] [Related]
13. An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.
Schmidt PJ; Toudjarska I; Sendamarai AK; Racie T; Milstein S; Bettencourt BR; Hettinger J; Bumcrot D; Fleming MD
Blood; 2013 Feb; 121(7):1200-8. PubMed ID: 23223430
[TBL] [Abstract][Full Text] [Related]
14. Effects of iron overload condition on liver toxicity and hepcidin/ferroportin expression in thalassemic mice.
Kumfu S; Chattipakorn SC; Fucharoen S; Chattipakorn N
Life Sci; 2016 Apr; 150():15-23. PubMed ID: 26921633
[TBL] [Abstract][Full Text] [Related]
15. Hepcidin knockout mice spontaneously develop chronic pancreatitis owing to cytoplasmic iron overload in acinar cells.
Lunova M; Schwarz P; Nuraldeen R; Levada K; Kuscuoglu D; Stützle M; Vujić Spasić M; Haybaeck J; Ruchala P; Jirsa M; Deschemin JC; Vaulont S; Trautwein C; Strnad P
J Pathol; 2017 Jan; 241(1):104-114. PubMed ID: 27741349
[TBL] [Abstract][Full Text] [Related]
16. Iron overload induces dysplastic erythropoiesis and features of myelodysplasia in Nrf2-deficient mice.
Duarte TL; Lopes M; Oliveira M; Santos AG; Vasco C; Reis JP; Antunes AR; Gonçalves A; Chacim S; Oliveira C; Porto B; Teles MJ; Moreira AC; Silva AMN; Schwessinger R; Drakesmith H; Henrique R; Porto G; Duarte D
Leukemia; 2024 Jan; 38(1):96-108. PubMed ID: 37857886
[TBL] [Abstract][Full Text] [Related]
17. Cardiac complications in beta-thalassemia: From mice to men.
Kumfu S; Fucharoen S; Chattipakorn SC; Chattipakorn N
Exp Biol Med (Maywood); 2017 Jun; 242(11):1126-1135. PubMed ID: 28485683
[TBL] [Abstract][Full Text] [Related]
18. TIMP3 deficiency exacerbates iron overload-mediated cardiomyopathy and liver disease.
Zhabyeyev P; Das SK; Basu R; Shen M; Patel VB; Kassiri Z; Oudit GY
Am J Physiol Heart Circ Physiol; 2018 May; 314(5):H978-H990. PubMed ID: 29373036
[TBL] [Abstract][Full Text] [Related]
19. Liver sinusoidal endothelial cells induce BMP6 expression in response to non-transferrin-bound iron.
Charlebois E; Fillebeen C; Presley J; Cagnone G; Lisi V; Lavallée VP; Joyal JS; Pantopoulos K
Blood; 2023 Jan; 141(3):271-284. PubMed ID: 36351237
[TBL] [Abstract][Full Text] [Related]
20. Nrf2 expression and function, but not MT expression, is indispensable for sulforaphane-mediated protection against intermittent hypoxia-induced cardiomyopathy in mice.
Zhou S; Wang J; Yin X; Xin Y; Zhang Z; Cui T; Cai J; Zheng Y; Liu Q; Cai L
Redox Biol; 2018 Oct; 19():11-21. PubMed ID: 30096613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
